.
Log In

IRB submissions that WILL BE accepted during the revised Common Rule form change period of 12/21/2018-1/21/2019:
  • Submission responses – All types (highly recommend submitting responses as soon as possible to limit issues within iMedRIS and the IRB application).
  • External IRB requests for administrative review
  • Amendments for KPR and DSMBs
  • Progress reports expiring between 12/10/2018 and 1/31/2019
  • Final Reports
  • Unanticipated Problems
  • Protocol Deviations
  • Suspension or premature termination by the sponsor or investigator
  • Federal agency (ex. FDA) or sponsor audit/inspection documentation or correspondence
IRB submissions that WILL NOT BE accepted during the form change period of 12/21/2018-1/21/2019:
  • All new research (Exempt, Expedited and Greater than Minimal risk)
  • Progress reports expiring after 1/31/2019
  • Amendments which require a revision to the currently approved IRB application (e.g., changes in consent process, inclusion/exclusion criteria, enrollment totals, or other protocol changes)

Please contact the IRB Office at 248-551-0662 with any questions.


Terms of Use | Privacy Statement
Copyright © 2001-2018 iMedRIS Data Corporation. All rights reserved.
Version 10.03.2 Build 699 Updated 2018/11/02 01:15